Blockchain Registration Transaction Record

Imugene CEO Discusses Enrolment for Bile Tract Cancer Expansion Study

Imugene CEO Leslie Chong discusses enrolment for a pivotal expansion study targeting bile tract cancer patients, following the successful completion of the VAXINIA monotherapy dose escalation study.

Imugene CEO Discusses Enrolment for Bile Tract Cancer Expansion Study

The news highlights the ongoing efforts of Imugene Ltd to advance innovative oncological treatments, with promising results in gastrointestinal cancers. The expansion study could provide hope for cholangiocarcinoma patients, and the presentation at the upcoming conference demonstrates the company's commitment to gathering support for its cutting-edge therapies.

Read More
BlockchainDetails
Contract Address0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71
Transaction ID0xea59cbc5823506eba7eb93f9c52d8fcf44601a7ae959f74d22d811ab7fa52845
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital FingerprintfaceLDil-98425f1a0d8fe5699d84afc9b4225806